Literature DB >> 33477523

The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion.

Marlena Schnieder1, Charlotte V Fischer-Wedi2, Sebastian Bemme2, Mai-Linh Kortleben2, Nicolas Feltgen2, Jan Liman1.   

Abstract

Central retinal artery occlusion (CRAO) is characterized by the sudden, painless loss of vision. Typical sonographic and optic coherence tomography (OCT) findings are a retrobulbar spot sign and prominent middle limiting membrane (p-MLM) sign. It remains uncertain whether the retrobulbar spot sign alone or coinciding with the appearance of p-MLM sign is a prognostic marker for visual acuity and the development of secondary retinal ischemia after CRAO. In our prospective cohort study, we included patients with a non-arteritic central artery occlusion < 4 weeks. We examined the following parameters at prespecified time points: ultrasound examination of orbital cavity, Spectral Domain-OCT examination, visual acuity test, and fundoscopy and ultra-widefield angiography to diagnose retinal vascularization. The presence of p-MLM sign in SD-OCT after CRAO was accompanied by significantly better vision during the first four weeks (2.3 (IQR 0.75) vs. 2.6 (IQR 0.33); p = 0.006). Moreover, the spot sign seems to be a prognostic factor for developing secondary retinal ischemia (8 (100%) vs. 0 (0%); p = 0.036). A retrobulbar spot sign seems to be a negative prognostic factor and is associated with secondary retinal ischemia, whereas a p-MLM sign is a somewhat positive prognostic factor for visual acuity.

Entities:  

Keywords:  central retinal artery occlusion; imaging; optical coherence tomography; prognosis; sudden vision loss; visual acuity

Year:  2021        PMID: 33477523      PMCID: PMC7831102          DOI: 10.3390/jcm10020338

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  29 in total

1.  Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial.

Authors:  Celia S Chen; Andrew W Lee; Bruce Campbell; Tien Lee; Mark Paine; Clare Fraser; John Grigg; Romesh Markus
Journal:  Stroke       Date:  2011-07-14       Impact factor: 7.914

2.  Resolving the clinical acuity categories "hand motion" and "counting fingers" using the Freiburg Visual Acuity Test (FrACT).

Authors:  C Lange; N Feltgen; B Junker; K Schulze-Bonsel; M Bach
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-03       Impact factor: 3.117

3.  Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test.

Authors:  Kilian Schulze-Bonsel; Nicolas Feltgen; Hermann Burau; Lutz Hansen; Michael Bach
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

4.  Retrobulbar Spot Sign Predicts Thrombolytic Treatment Effects and Etiology in Central Retinal Artery Occlusion.

Authors:  Max Nedelmann; Michael Graef; Frank Weinand; Klaus-Heiko Wassill; Manfred Kaps; Birgit Lorenz; Christian Tanislav
Journal:  Stroke       Date:  2015-06-25       Impact factor: 7.914

Review 5.  Management of Transient Monocular Vision Loss and Retinal Artery Occlusions.

Authors:  Ivana Vodopivec; Dean M Cestari; Joseph F Rizzo
Journal:  Semin Ophthalmol       Date:  2016-10-26       Impact factor: 1.975

6.  In vivo detection of acute ischemic damages in retinal arterial occlusion with optical coherence tomography: a "prominent middle limiting membrane sign".

Authors:  Young Kwang Chu; Young Taek Hong; Suk Ho Byeon; Oh Woong Kwon
Journal:  Retina       Date:  2013 Nov-Dec       Impact factor: 4.256

7.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

8.  Low endogenous recanalization in embolic central retinal artery occlusion--the retrobulbar "spot sign".

Authors:  Mathias Altmann; Michael Ertl; Horst Helbig; Beate Schömig; Ulrich Bogdahn; Maria-Andreea Gamulescu; Felix Schlachetzki
Journal:  J Neuroimaging       Date:  2014-03-19       Impact factor: 2.486

9.  Embolic strokes of undetermined source: the case for a new clinical construct.

Authors:  Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly
Journal:  Lancet Neurol       Date:  2014-04       Impact factor: 44.182

10.  Vascular risk factors for central retinal artery occlusion.

Authors:  A K Rudkin; A W Lee; C S Chen
Journal:  Eye (Lond)       Date:  2009-06-12       Impact factor: 3.775

View more
  1 in total

1.  Inner Retinal Layer Hyperreflectivity Is an Early Biomarker for Acute Central Retinal Artery Occlusion.

Authors:  Daniel A Wenzel; Sven Poli; Maria Casagrande; Vasyl Druchkiv; Martin S Spitzer; Karl Ulrich Bartz-Schmidt; Carsten Grohmann; Maximilian Schultheiss
Journal:  Front Med (Lausanne)       Date:  2022-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.